Edinburgh Research Explorer

Oncogenic activity of SOX1 in glioblastoma

Research output: Contribution to journalArticle

  • Idoia Garcia
  • Juncal Aldaregia
  • Jelena Marjanovic Vicentic
  • Paula Aldaz
  • Leire Moreno-Cugnon
  • Sergio Torres-Bayona
  • Estefania Carrasco-Garcia
  • Laura Garros-Regulez
  • Larraitz Egaña
  • Angel Rubio
  • Steven Pollard
  • Milena Stevanovic
  • Nicolas Sampron
  • Ander Matheu

Related Edinburgh Organisations

Open Access permissions

Open

Documents

  • Download as Adobe PDF

    Rights statement: This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

    Final published version, 1.61 MB, PDF document

    Licence: Creative Commons: Attribution (CC-BY)

Original languageEnglish
Pages (from-to)46575
JournalScientific Reports
Volume7
Early online date20 Apr 2017
DOIs
Publication statusE-pub ahead of print - 20 Apr 2017

Abstract

Glioblastoma remains the most common and deadliest type of brain tumor and contains a population of self-renewing, highly tumorigenic glioma stem cells (GSCs), which contributes to tumor initiation and treatment resistance. Developmental programs participating in tissue development and homeostasis re-emerge in GSCs, supporting the development and progression of glioblastoma. SOX1 plays an important role in neural development and neural progenitor pool maintenance. Its impact on glioblastoma remains largely unknown. In this study, we have found that high levels of SOX1 observed in a subset of patients correlate with lower overall survival. At the cellular level, SOX1 expression is elevated in patient-derived GSCs and it is also higher in oncosphere culture compared to differentiation conditions in conventional glioblastoma cell lines. Moreover, genetic inhibition of SOX1 in patient-derived GSCs and conventional cell lines decreases self-renewal and proliferative capacity in vitro and tumor initiation and growth in vivo. Contrarily, SOX1 over-expression moderately promotes self-renewal and proliferation in GSCs. These functions seem to be independent of its activity as Wnt/β-catenin signaling regulator. In summary, these results identify a functional role for SOX1 in regulating glioma cell heterogeneity and plasticity, and suggest SOX1 as a potential target in the GSC population in glioblastoma.

    Research areas

  • Journal Article

Download statistics

No data available

ID: 38583406